指南与共识复苏、休克与脓毒症儿科与产科急症

2024 RECOVER指南:犬猫心肺复苏治疗推荐更新

2024 RECOVER Guidelines: Updated treatment recommendations for CPR in dogs and cats.
指南 / 共识 · J Vet Emerg Crit Care (San Antonio) · 2024-01-01
一句话结论2024 RECOVER指南更新犬猫CPR推荐:不再推荐大剂量肾上腺素,阿托品若使用仅给一次,非插管动物优先球囊面罩通气。

该指南为2012年RECOVER兽医CPR指南的更新,涵盖基础生命支持(BLS)、高级生命支持(ALS)和围停搏监测。采用改良GRADE系统,基于PICO格式的优先临床问题系统检索文献并评估证据质量,最终形成90条治疗推荐。主要变化包括:不再推荐大剂量肾上腺素;阿托品若使用仅给药一次;非插管动物优先选择球囊面罩通气而非口对口鼻通气。指南还提供了初始评估流程、更新的CPR流程、节律诊断工具和更新药物剂量表。

要点

  • 不再推荐大剂量肾上腺素用于犬猫CPR。
  • 阿托品若使用,仅给药一次。
  • 非插管动物优先选择球囊面罩通气而非口对口鼻通气。
  • 指南提供初始评估流程、更新CPR流程、节律诊断工具和更新药物剂量表。
  • 多数BLS和ALS推荐不变,部分因过去10年新证据而修改。

适用人群与场景

  • 犬和猫的心肺复苏(CPR)场景,涵盖基础生命支持(BLS)、高级生命支持(ALS)和围停搏监测。

处置流程与药物剂量

  • 不再推荐大剂量肾上腺素。
  • 阿托品若使用,仅给药一次。
  • 非插管动物优先选择球囊面罩通气而非口对口鼻通气。

研究设计与关键结果

  • 共制作40份工作表评估BLS、ALS和监测3个领域的问题,形成90条个体化治疗推荐。
  • 高剂量肾上腺素不再被推荐。
  • 阿托品若使用仅给药一次。
  • 非插管动物优先球囊面罩通气而非口对口鼻通气。
  • 提供初始评估流程、更新CPR流程、节律诊断工具和更新药物剂量表。

证据类型、等级与局限

  • 证据类型:指南(基于改良GRADE系统的证据评估与共识推荐)。
  • 证据间接性仍是指南制定确定性的最大障碍,凸显需要在目标物种(犬和猫)中开展更多研究。
  • 局限:证据间接性仍是指南制定确定性的最大障碍,凸显需要在目标物种(犬和猫)中开展更多研究。

对床旁实践的改变

  • 犬猫CPR中不再使用大剂量肾上腺素。
  • 阿托品若使用,仅给药一次。
  • 非插管动物优先选择球囊面罩通气而非口对口鼻通气。
  • 多数BLS和ALS推荐不变,部分因过去10年新证据而修改。

指南或共识出处

  • 2024 RECOVER指南:犬猫心肺复苏治疗推荐更新(J Vet Emerg Crit Care (San Antonio))。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: After the 2012 Reassessment Campaign on Veterinary Resuscitation (RECOVER) CPR Guidelines, this is an update of evidence-based consensus guidelines for Basic Life Support (BLS), advanced life support (ALS), and periarrest monitoring.

DESIGN: These RECOVER CPR Guidelines were generated using a modified version of the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system for evidence evaluation and translation of this evidence into clear and actionable clinical instructions. Prioritized clinical questions in the Population, Intervention, Comparator, and Outcome (PICO) format were used as the basis to conduct systematic literature searches by information specialists, to extract information from relevant publications, to assess this evidence for quality, and finally to translate the findings into treatment recommendations. These recommendations were reviewed by the RECOVER writing group and opened for comment by veterinary professionals for 4 weeks.

SETTING: Transdisciplinary, international collaboration in university, specialty, and emergency practice.

RESULTS: A total of 40 worksheets were prepared to evaluate questions across the 3 domains of BLS, ALS and Monitoring, resulting in 90 individual treatment recommendations. High-dose epinephrine is no longer recommended, and atropine, if used, is only administered once. Bag-mask ventilation is prioritized over mouth-to-nose ventilation in nonintubated animals. In addition, an algorithm for initial assessment, an updated CPR algorithm, a rhythm diagnosis tool, and an updated drug dosing table are provided.

CONCLUSIONS: While the majority of the BLS and ALS recommendations remain unchanged, some noteworthy changes were made due to new evidence that emerged over the past 10 years. Indirectness of evidence remains the largest impediment to the certainty of guidelines formulation and underscores an urgent need for more studies in the target species of dogs and cats.

来源:J Vet Emerg Crit Care (San Antonio),查看原文。版权归原作者所有。

参考来源

  1. Burkitt-Creedon JM, Boller M, Fletcher DJ, et al. 2024 RECOVER Guidelines: Updated treatment recommendations for CPR in dogs and cats. J Vet Emerg Crit Care (San Antonio). 2024. PMID: 38924627. doi:10.1111/vec.13391

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。